All In Biotech

Free tool

FAERS Monitor: Lithium Carbonate

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 017812 or its brand name (Lithium Carbonate, Lithium Carbonate). Reports on generic versions are filed under their own applications.

Reports

16,493

Serious

13,263

80% of reports

Hospitalization

7,052

Death reported

1,210

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • toxicity to various agents1,246
  • drug ineffective1,124
  • tremor1,066
  • drug interaction999
  • nausea811
  • weight increased794
  • insomnia698
  • depression693
  • fatigue671
  • vomiting663
  • confusional state636
  • somnolence627
  • anxiety596
  • off label use590
  • suicide attempt578

Reports by year received

View as table
YearReports
2004530
2005452
2006746
20071,023
2008723
2009826
2010798
20111,114
20121,406
2013499
2014398
2015615
2016694
2017584
2018717
2019677
2020687
2021762
2022740
2023723
2024654
2025594
2026531

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,037,666 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
suicide attemptSignal57812.311.35,929
toxicity to various agentsSignal1,2469.59.09,455
tremorSignal1,0668.27.86,781
drug interactionSignal9998.17.66,193
confusional stateSignal6365.04.72,060
weight increasedSignal7944.54.22,199
somnolenceSignal6274.03.71,405
depressionSignal6933.93.61,499
insomniaSignal6983.33.11,159
anxietySignal5962.72.5630
vomiting6631.81.7240
nausea8111.31.260
fatigue6711.11.06
drug ineffective1,1241.11.08
off label use5900.90.814

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.